AbbVie Inc.
ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF
Last updated:
Abstract:
The invention relates generally to conjugated activatable antibodies that bind CD71 in their active form and methods of making and using these anti-CD71 conjugated activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Status:
Application
Type:
Utility
Filling date:
25 Nov 2020
Issue date:
20 May 2021